Clinical Trial Update: Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of Carmustine wafers and Irinotecan for patients with recurrent supratentorial high-grade gliomas has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• Carmustine wafers (carmustine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED